Published in Obes Res on October 01, 2005
Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child (2007) 1.10
Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study. Cardiovasc Diabetol (2007) 1.10
Cardiometabolic risk variables in overweight and obese children: a worldwide comparison. Cardiovasc Diabetol (2011) 1.05
Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab (2008) 0.95
Vascular risks and management of obesity in children and adolescents. Vasc Health Risk Manag (2006) 0.93
Taking Action Together: a YMCA-based protocol to prevent type-2 diabetes in high-BMI inner-city African American children. Trials (2010) 0.87
Effects of visfatin gene polymorphism RS4730153 on exercise-induced weight loss of obese children and adolescents of Han Chinese. Int J Biol Sci (2012) 0.83
Association of BMI and fasting insulin with cardiovascular disease risk factors in seven-year-old Icelandic children. Scand J Prim Health Care (2009) 0.82
Metabolic syndrome in a sample of the 6- to 16-year-old overweight or obese pediatric population: a comparison of two definitions. Ther Clin Risk Manag (2012) 0.82
Sex dimorphisms in inflammatory markers and adiposity in African-American youth. Int J Pediatr Obes (2010) 0.81
Obesity and metabolic syndrome in 7-9 years-old Portuguese schoolchildren. Diabetol Metab Syndr (2010) 0.81
Tyrosine Is Associated with Insulin Resistance in Longitudinal Metabolomic Profiling of Obese Children. J Diabetes Res (2015) 0.80
Metabolic syndrome and insulin resistance in obese adolescents. Rev Paul Pediatr (2014) 0.77
Treatment of pediatric obesity using a parent-only approach: a case example. Health Psychol (2013) 0.76
Evaluation of Periaortic Adiposity and Metabolic Disorders in Obese Children. J Clin Res Pediatr Endocrinol (2015) 0.75
A family-centered lifestyle intervention to improve body composition and bone mass in overweight and obese children 6 through 8 years: a randomized controlled trial study protocol. BMC Public Health (2013) 0.75
Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics (2004) 2.10
Definable somatic disorders in overweight children and adolescents. J Pediatr (2007) 1.71
Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am J Clin Nutr (2006) 1.65
Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism (2006) 1.63
Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity. Pediatr Diabetes (2005) 1.56
Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol (2007) 1.46
Changes of cardiovascular risk factors in obese children effects of inpatient and outpatient interventions. J Pediatr Gastroenterol Nutr (2006) 1.41
Thyroid hormones and their relation to weight status. Horm Res (2008) 1.28
Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab (2006) 1.27
Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child (2007) 1.10
Androgens before and after weight loss in obese children. J Clin Endocrinol Metab (2005) 1.07
Cardiovascular risk factors in overweight German children and adolescents: relation to gender, age and degree of overweight. Nutr Metab Cardiovasc Dis (2005) 1.05
Pain in pediatric oncology--children's and parents' perspectives. Eur J Pain (2005) 1.04
Paediatric cancer pain management using the WHO analgesic ladder--results of a prospective analysis from 2265 treatment days during a quality improvement study. Eur J Pain (2005) 1.04
Intima-media thickness in obese children before and after weight loss. Pediatrics (2006) 1.03
High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children. Metabolism (2005) 1.02
Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin Endocrinol (Oxf) (2007) 0.96
Parental diabetes, pubertal stage, and extreme obesity are the main risk factors for prediabetes in children and adolescents: a simple risk score to identify children at risk for prediabetes. Pediatr Diabetes (2008) 0.96
Relationship between metabolic syndrome definitions for children and adolescents and intima-media thickness. Atherosclerosis (2007) 0.95
Cortisol and its relation to insulin resistance before and after weight loss in obese children. Horm Res (2004) 0.95
Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage. Int J Biol Sci (2007) 0.94
A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents. Sleep Breath (2009) 0.93
Simultaneous analysis of coenzyme Q10 in plasma, erythrocytes and platelets: comparison of the antioxidant level in blood cells and their environment in healthy children and after oral supplementation in adults. Clin Chim Acta (2004) 0.91
Long-term follow-up of overweight children: after training, after a single consultation session, and without treatment. J Pediatr Gastroenterol Nutr (2003) 0.90
Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids. Metabolism (2005) 0.88
Antioxidant level and redox status of coenzyme Q10 in the plasma and blood cells of children with diabetes mellitus type 1. Pediatr Diabetes (2008) 0.87
Amylin and its relation to insulin and lipids in obese children before and after weight loss. Obesity (Silver Spring) (2007) 0.86
Medical care of obese children and adolescents. APV: a standardised multicentre documentation derived to study initial presentation and cardiovascular risk factors in patients transferred to specialised treatment institutions. Eur J Pediatr (2004) 0.85
Leptin concentrations are a predictor of overweight reduction in a lifestyle intervention. Int J Pediatr Obes (2009) 0.84
Precocious pseudopuberty due to autonomous ovarian cysts: a report of ten cases and long-term follow-up. Hormones (Athens) (2008) 0.82
The impact of insulin resistance and hyperandrogenemia on polysomnographic variables in obese adolescents with polycystic ovarian syndrome. Sleep Breath (2011) 0.81
Fasting glucagon-like peptide-1 and its relation to insulin in obese children before and after weight loss. J Pediatr Gastroenterol Nutr (2007) 0.81
Relationships of IGF-I and andrrogens to skeletal maturation in obese children and adolescents. J Pediatr Endocrinol Metab (2006) 0.81
Compound heterozygous and homozygous mutations of the TSHbeta gene as a cause of congenital central hypothyroidism in Europe. Horm Res (2004) 0.81
Coenzyme Q10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia. Clin Chim Acta (2002) 0.81
Comparison of coenzyme Q10 plasma levels in obese and normal weight children. Clin Chim Acta (2004) 0.81
Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome. J Sleep Res (2010) 0.81
Plasma levels and redox status of coenzyme Q10 in infants and children. Biofactors (2004) 0.80
Risk factors for impaired glucose tolerance in obese children and adolescents. World J Diabetes (2010) 0.80
Coenzyme Q10 concentration in plasma and blood cells: what about diurnal changes? Biofactors (2006) 0.78
Plasma levels of coenzyme Q10 in children with hyperthyroidism. Horm Res (2003) 0.78
Longitudinal analyses of polysomnographic variables, serum androgens, and parameters of glucose metabolism in obese adolescents with polycystic ovarian syndrome. Sleep Breath (2011) 0.77
Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and growth in obese children before and after reduction of overweight. J Pediatr Endocrinol Metab (2009) 0.77
A comparison of polysomnographic variables between adolescents with polycystic ovarian syndrome with and without the metabolic syndrome. Metab Syndr Relat Disord (2011) 0.77
Association between leptin and transaminases: 1-year follow-up study in 180 overweight children. Metabolism (2009) 0.76
Coenzyme Q10 concentration in the plasma of children suffering from acute lymphoblastic leukaemia before and during induction treatment. Biofactors (2007) 0.76
Plasma and thrombocyte levels of coenzyme Q10 in children with Smith-Lemli-Opitz syndrome (SLOS) and the influence of HMG-CoA reductase inhibitors. Biofactors (2008) 0.76
Coenzyme Q10 in maternal plasma and milk throughout early lactation. Biofactors (2005) 0.75
Coenzyme Q10 concentration in plasma and blood cells of juvenile patients hospitalized for anorexia nervosa. Biofactors (2012) 0.75